Excellent tool
It’s an excellent tool to manage sales leads. Now, I can do all the communication with the leads only using this app. The omnichannel feature is phenomenal.
Free
About
Streamline clinic operations with a mobile app for managing patient inquiries, appointments, and follow-ups. Stay connected and never miss a patient interaction, even remotely. Features include real-time lead management and automated follow-ups.
✓Unified communication
✓Patient inquiry management
✓Appointment scheduling
✓Real-time lead management
✓Instant notifications
✓Automated follow-ups
Show original description
What's New in My ClinicOS
2.0.16
May 28, 2025
Profile UI updated
User reviews
Developer apps
FAQ
What is My ClinicOS?
My ClinicOS is a mobile application designed to help clinics manage patient inquiries, appointments, and follow-ups. It offers unified communication and real-time lead management to ensure no patient interaction is missed.
Is My ClinicOS free to use?
Yes, My ClinicOS is available for free. The app is priced at $0.00 and does not have any in-app purchases or advertisements.
What devices does My ClinicOS support?
My ClinicOS is currently supported on iPhone and iPod devices. It is not yet available for Android or other platforms.
How often is My ClinicOS updated?
The app was last updated on May 28, 2025, with version 2.0.16. This indicates a recent update, suggesting the developer is actively maintaining the application.
What age rating does My ClinicOS have?
My ClinicOS has an age rating of 17+. This is likely due to the nature of managing sensitive patient information and the professional context of the application.
What are the key features of My ClinicOS?
Key features include real-time lead management, instant notifications for new inquiries, smart lead qualification, and automated follow-ups, all aimed at improving clinic communication and efficiency.
Who developed My ClinicOS?
My ClinicOS was developed by SEVEN ZERO TECHNOLOGIES LTD. They are the publisher responsible for the app's development and updates.